Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2025-05-07 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
百济神州有限公司2025年第一季度主要财务数据公告
Interim / Quarterly Report Classification · 95% confidence The document is titled as "2025年第一季度主要财务数据公告" which translates to "2025 First Quarter Major Financial Data Announcement." It contains detailed financial data for the first quarter of 2025, including revenue, profit, net income, and other financial metrics. The data is preliminary and unaudited, with a note that the final audited data will be disclosed in the company's formal quarterly report. The document also includes explanations of business performance, product sales, and future outlook. The length is 6605 characters, which is sufficient to contain substantive financial data and analysis. This matches the definition of an Interim / Quarterly Report (IR), which must contain actual financial statements or substantive financial data and analysis for a period shorter than a full fiscal year. The document is not merely an announcement of a report or a certification, but contains detailed financial figures and business commentary. Therefore, the correct classification is IR with high confidence. Q1 2025
2025-05-07 Chinese
美股公告：表格F-6/A
Regulatory Filings Classification · 95% confidence The document is a Form F-6 registration statement filed with the U.S. Securities and Exchange Commission (SEC) under the Securities Act of 1933. It relates to American Depositary Shares (ADS) representing ordinary shares of BeiGene Ltd. The text includes detailed information about the depositary agreement, terms of the ADS, rights of holders, and related legal and procedural details. It is a registration statement for securities, not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and depositary shares, not an announcement or a report like an annual report or interim report. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial and contains detailed legal and regulatory information, confirming it is not a brief announcement or a certification letter but a full regulatory filing.
2025-05-05 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 95% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares of a listed company, including share issuance under equity plans, share repurchases, and stock option exercises. It references specific Hong Kong Stock Exchange Listing Rules (Main Board and GEM) sections 13.25A, 17.27A, 10.06(4)(a), and others, which govern disclosure of share capital changes. The document includes tables of share counts before and after events, prices per share, and confirmations of compliance with listing rules. It is not an annual or interim financial report, nor an earnings release or management discussion. It is not a proxy statement or AGM material. It is a regulatory disclosure specifically about share capital changes and share repurchases. This fits the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues, stock splits, or other capital changes. The document length is about 4547 characters, which is substantive and contains detailed data, not just an announcement of a report publication. Therefore, the correct classification is SHA with high confidence.
2025-05-05 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 100% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares, including share issuance under equity plans and share repurchases, with references to Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes specific share counts, dates, prices, and confirmations of compliance with listing rules. The document is titled as a "翌日披露報表" which translates to "Next Day Disclosure Report" related to share issuance and treasury stock changes. It is not an announcement of a report publication but the actual disclosure itself. This type of document corresponds to announcements regarding share issues or capital changes, specifically share issuance and treasury stock movements. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is 4053 characters, which is sufficient to contain substantive data, not just a brief announcement or certification. Hence, it is not RPA or RNS.
2025-04-30 Chinese
百济神州有限公司关于公司涉及诉讼的进展公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding the progress of a legal proceeding involving the company 百济神州有限公司. It details the status of a patent infringement lawsuit, the company's position, the impact on operations, and risk warnings. There are no financial statements, earnings data, or management discussion of financial results. The document is focused solely on legal proceedings and updates related to a lawsuit. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is 2192 characters, which is consistent with a detailed announcement but not a full financial report. Hence, the classification is LTR with high confidence.
2025-04-30 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 95% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares, including share issuance under equity plans and share repurchases, with references to Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes specific dates, share counts, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure related to share capital changes rather than a full financial report or announcement of a report. It is not an announcement of a report publication but a substantive disclosure of share capital movements. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 4053 characters, which is substantive enough to be a report rather than a brief announcement.
2025-04-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.